Evidence map›Paper›PMID 29855833›Full record

SynthesisAnnals of surgical oncology2018

Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients.

Rajshri M Gartland, Carrie C Lubitz

Abstract readSystematic Review
In one paragraph

Synthesis in Annals of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Patient-reported outcomes following total thyroidectomy and lobectomy in thyroid cancer survivors: an analysis of the PROFILES Registry data.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  18. Article
  19. Article
  20. Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.Thyroid : official journal of the American Thyroid Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Rajshri M GartlandDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Carrie C LubitzDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. clubitz@partners.org.
Harvard University · USMassachusetts General Hospital · US

Funding

Thyroid Nodule Treatment Optimization: A Personalized ApproachR37CA231957 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CUNNINGHAM, CARRIE ELIZABETH · 2019 to 2025
$3.6M
Optimization of Treatment of Papillary Thyroid Cancer: A Risk-tailored ApproachK07CA177900 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CUNNINGHAM, CARRIE ELIZABETH · 2014 to 2018
$712k
NCI NIH HHS K07 CA177900NCI NIH HHS L30 CA179825NCI NIH HHS R37 CA231957
6 · The paper itself

Abstract

backgroundThe extent of surgery for low-risk papillary thyroid cancer (PTC) has been the subject of debate among experts for decades.

objectiveIn this paper, we aimed to systematically review whether thyroid lobectomy versus total thyroidectomy for PTC patients with tumors measuring 1.0-4.0 cm impacts tumor recurrence and survival.

resultsA systematic review of the literature from January 1990 to February 2018 yielded 13 relevant studies, including eight national cancer registry database studies, one multi-institutional thyroid cancer-specific database, three large-scale institutional series, and one meta-analysis. Data from these studies demonstrate that total thyroidectomy for the treatment of PTC measuring 1.0-4.0 cm does not confer a clinically significant improvement in disease-specific survival compared with thyroid lobectomy. Four of six studies also reported that total thyroidectomy is associated with a small but statistically significant improvement in disease-free survival, although it is argued whether this difference is clinically significant.

conclusionsWhile the quality of the data limit the strength of our conclusions, and while tumor characteristics, patient risk factors, and preferences should be considered, most data support that lobectomy and total thyroidectomy yield comparable oncologic outcomes for PTC measuring 1.0-4.0 cm.

Indexed as

Neoplasm Recurrence, LocalDisease-Free SurvivalHumansSurvival RateThyroid Cancer, PapillaryThyroidectomyThyroid NeoplasmsTumor Burden

Identifiers

PMID29855833
PMCPMC6070400
OpenAlexW2807533846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.